ELVN
NASDAQ · Pharmaceuticals
Enliven Therapeutics Inc
$48.62
+0.02 (+0.04%)
Open$48.71
Previous Close$48.60
Day High$49.47
Day Low$48.51
52W High$48.53
52W Low$14.79
Volume—
Avg Volume2.65M
Market Cap3.22B
P/E Ratio—
EPS$-1.66
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
-34.9% upside
Current
$48.62
$48.62
Target
$31.67
$31.67
$20.91
$31.67 avg
$36.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 263.34M | 235.73M | 210.63M |
| Net Income | 79.58M | 63.75M | 57.56M |
| Profit Margin | 30.2% | 27.0% | 27.3% |
| EBITDA | 141.73M | 119.11M | 111.32M |
| Free Cash Flow | 52.28M | 61.02M | 35.31M |
| Rev Growth | -0.5% | +12.7% | -7.4% |
| Debt/Equity | 0.42 | 0.43 | 0.43 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,114.20 | +0.64% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $240.15 | +0.45% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $121.17 | +1.31% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.09 | -2.55% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.15 | +1.70% | 12.5 | 33.00B |